Literature DB >> 29593987

Luteal phase support for documented failure of placental steroidogenesis: A case report.

Bryan Kratz1, Amer Rasheed1, John P Holden1.   

Abstract

OBJECTIVE: To report a case of a habitual aborter that had a pregnancy reach near term and successfully delivered a viable female infant.
DESIGN: Report of a unique case of a G10P1 that was successfully able to maintain a pregnancy by maintaining serum levels of estradiol and progesterone at or above 200 pg/dL and 25 ng/dL respectively. This case provides a benchmark for exogenous support of estradiol and progesterone throughout pregnancy.
SETTING: A private advanced reproductive center. PATIENT: 39-year-old G10P1091 diagnosed to have antiphospholipid syndrome but continued to have continuous miscarriages despite accepted treatment. In addition, 8 products of conception were sent for cytogenetic testing and all were found to be normal.
INTERVENTIONS: Examination, laboratory studies, imaging, clinical judgment, and knowledge of previous treatment failures were used to guide the treatment of this patient. Fertility was achieved with continuous supplementation of progesterone, estrogen, LMW-heparin, and prednisone. MAIN OUTCOME MEASURE: Delivery of viable infant.
RESULTS: This advanced reproductive age woman had three subsequent pregnancies. While compliant with our prescribed protocol, the patient successfully carried two pregnancies to viability.
CONCLUSION: Clinicians should be alert to the possibility of a luteal phase defect when a patient presents with recurrent fertility problems and multiple spontaneous abortions.

Entities:  

Keywords:  Infertility; Luteal phase defect; Progesterone; Spontaneous abortion

Year:  2016        PMID: 29593987      PMCID: PMC5842957          DOI: 10.1016/j.crwh.2016.12.002

Source DB:  PubMed          Journal:  Case Rep Womens Health        ISSN: 2214-9112


  9 in total

Review 1.  Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.

Authors:  E A Pritts; A K Atwood
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

2.  Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization.

Authors:  Asha Proctor; Bradley S Hurst; Paul B Marshburn; Michelle L Matthews
Journal:  Fertil Steril       Date:  2006-04-17       Impact factor: 7.329

3.  Recent advances in medically assisted conception. Report of a WHO Scientific Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1992

4.  Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.

Authors: 
Journal:  Fertil Steril       Date:  2008-11       Impact factor: 7.329

Review 5.  Progestogen for preventing miscarriage.

Authors:  David M Haas; Patrick S Ramsey
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

6.  The clinical relevance of luteal phase deficiency: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2012-07-20       Impact factor: 7.329

7.  Unexplained recurrent miscarriage: how can we explain it?

Authors:  Sotirios H Saravelos; Tin-Chiu Li
Journal:  Hum Reprod       Date:  2012-05-02       Impact factor: 6.918

Review 8.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan Am Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

Review 9.  Human chorionic gonadotrophin (hCG) for preventing miscarriage.

Authors:  Lara C Morley; Nigel Simpson; Thomas Tang
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.